Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building ...
President Trump is rapidly expanding Section 232 tariffs on diverse imports, including pharmaceuticals and machinery, as a backup against potential Supreme Court rulings on his earlier tariffs. These ...
In a conversation with Anees Hussain, Santosh Vishwanathan, Vice President and Managing Director of Intel India, talks about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback